Response to the 2020 American College of Rheumatology Guideline for the Management of Gout: Comment on the Article by FitzGerald et al
Arthritis Care Res (Hoboken)
.
2020 Oct;72(10):1506-1507.
doi: 10.1002/acr.24379.
Authors
Peter E Lipsky
1
,
N Lawrence Edwards
2
,
Theodore R Fields
3
,
Robert T Keenan
4
,
Brian F Mandell
5
,
Naomi Schlesinger
6
Affiliations
1
RILITE Research Institute, Charlottesville, Virginia.
2
University of Florida, Gainesville, Florida.
3
Hospital for Special Surgery, New York, New York.
4
Duke University, Durham, North Carolina.
5
Cleveland Clinic Foundation, Cleveland, Ohio.
6
Robert Wood Johnson Medical School, Rutgers University, New Brunswick, New Jersey.
PMID:
32702211
DOI:
10.1002/acr.24379
No abstract available
Publication types
Letter
Comment
MeSH terms
Antirheumatic Agents*
Gout* / diagnosis
Gout* / drug therapy
Humans
Rheumatology*
United States / epidemiology
Universities
Substances
Antirheumatic Agents